Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

NCT04490707 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia in Remission

Interventions

DRUG: Azacitidine
DRUG: Lenalidomide

Sponsor

Ge Zheng